Applied understanding of Post Covid Coagulopathy Disorders through Ayurveda
Abstract
Blood is the only fluid connective tissue in the body, maintains life and plays vital role in the body, Acharya Vagbhata describes the function Rakta as Jeevanam and Sharkadhara explains it under ten Nanatmaja Vyadhi , and as per Acharya Sushruta Raktamokshana as Ardhachikitsa and he had also described Rakta as the Chaturtha Dosha, hence all the Coagulopathy disorders can be understood under the disorders of Rakta Pradoshaja Vikara. Coagulopathy are caused by disruption in the body’s ability to control blood clotting. In the present situation i.e., Pandemic Covid-19, patients with Covid-19 pneumonia exhibits coagulation abnormalities, most commonly elevated D-dimer has been associated with a higher mortality rate. Covid-19 causes a spectrum of disease, with frequent involvement of the hemostatic system. Severe pulmonary inflammation causes activation and may trigger pulmonary thrombosis early in the disease course. So, when compared to other Post Covid -19 Complication, Coagulopathy plays a most important role.
Downloads
References
https ://www. Karger.com. Review article – By Wool G.D.Miller J.L. The impact of COVID -19 disease on platelets and Coagulation.
Pub med .Gov. Review: Viral infection and mechanism of thrombosis and bleeding
www.health Harvard. edu article on Warfarin users be aware of antibiotics at June 1,2021.
www.rexlist.com Doxycyline :generic
https://www.nature.com article on effects of corticosteroids on Coagulation of the blood
Agnivesh, Charaka Samhita Ayurveda Deepika tika of Chakrapani, chaukhambha publications New Dehli edition 2016 Nidana sthana 8th chapter, verse- 16-19 pg no -227
https://www.news-medical.net article on –What is D-Dimer?
https://www.medllineplus.gov article on-c-Reactive Protein (CRP) Test –MedlinePlus
https://www.mayoclinicalabs.com article on-Test ID:IL6 Interleukin 6,Plsma-Mayo Clinic Laboratories
https://ww.webmed.com article on-What is Lactate Dehydrogenase(LDH)Test- Review by Melinda ratini Do,Ms on August 5,2019.
Sri Madhavakara with The Madhukosha Sanskrit Commentary By- Srivijaraksita and Srikanthadatta with The Vidyotini Hindi Commentary and notes of Madhava Nidana chaukhambha publications Varanasi Part-1 2nd chapter sloka no.70-72
Sri Madhavakara with The Madhukosha Sanskrit Commentary By- Srivijaraksita and Srikanthadatta with The Vidyotini Hindi Commentary and notes of Madhava Nidana chaukhambha publications Varanasi Part-1 2nd chapter sloka no.60-70
Susruta. Susruta Samhita,Dalhana tika of nibhnda sangraha, Chaukhamba Varanasi edition 2015 Shareera Sthana 4th chapter Sloka no.12,13 Pg no353
Agnivesh, Charaka samhita Ayurveda deepika tika of Chakrapani, chaukhambha publications New Dehli edition 2016 Chikitsa Sthana 3rd chapter Sloka no.-145 pg no.410
Agnivesh, Charaka samhita Ayurveda deepika tika of chakrapani, chaukhambha publications New Dehli edition 2016 Chikitsa sthana 3rd chapter Sloka no.-200 pg no.417
Agnivesh, Charaka Samhita Ayurveda deepika tika of Chakrapani, chaukhambha publications New Dehli edition 2016 Sutra sthana4th chapter Sloka no.-8 pg no.32
Vagbhata, Astanga Hrudaya, Sarvanga Sundara of Arunadatta and Ayurveda Rasayana of Hemadri Chaukhamba, Varanasi edition 2015 Sutrasthana 10th chapter Sloka no. 18 pg no.176
Vruddha Vagbhata, Astanga Sangraha Sasilekha Sanskrita commentary By Indu Chaukhamba publications, Varanasi Chikitsa Sthana 24th chapter sloka no.18 pg no-586
Susruta -Susruta samhita,Dalhana tika of nibhnda sangraha,Chaukhmba Varanasi edition 2015 Sutra Sthana 14th chapter Sloka no.35 pg no.65
Copyright (c) 2022 Mukta, Pramod Katti
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.